+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

IVF Disposables Market 2023-2027

  • PDF Icon

    Report

  • 153 Pages
  • July 2023
  • Region: Global
  • TechNavio
  • ID: 4577514
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The IVF disposables market is forecasted to grow by USD 248.53 mn during 2022-2027, accelerating at a CAGR of 7.66% during the forecast period. The report on the IVF disposables market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing infertility rates, partnership and collaboration among players, and increasing healthcare expenditure by individuals.

The IVF disposables market is segmented as below:

By End-user

  • Clinics
  • Hospitals

By Type

  • Petri dishes
  • Tubes
  • Catheters
  • Kits
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the technological advancements in IVF procedure as one of the prime reasons driving the IVF disposables market growth during the next few years. Also, robust growth of healthcare industry and high investment in research and development will lead to sizable demand in the market.

The report on the ivf disposables market covers the following areas:

  • IVF disposables market sizing
  • IVF disposables market forecast
  • IVF disposables market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading ivf disposables market vendors that include BIOPSYBELL Srl, Boston IVF, CCD Laboratory, Cook Group Inc., Esco Micro Pte. Ltd., FUJIFILM Corp., Genea Ltd., Hamilton Thorne Ltd., INVO Bioscience Inc., KITAZATO Corp., LabIVF Asia Pte Ltd., Merck KGaA, NidaCon International AB, Progyny Inc., Rocket Medical Plc, Sysmex Corp., Tempest Therapeutics Inc., The Cooper Companies Inc., Thermo Fisher Scientific Inc., and Vitrolife AB. Also, the IVF disposables market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

PART 01: EXECUTIVE SUMMARYPART 02: SCOPE OF THE REPORTPART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
  • Market ecosystem

  • Market characteristics

  • Market segmentation analysis
PART 05: MARKET SIZING
  • Market definition

  • Market sizing 2017

  • Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
  • Bargaining power of buyers

  • Bargaining power of suppliers

  • Threat of new entrants

  • Threat of substitutes

  • Threat of rivalry

  • Market condition
PART 07: CUSTOMER LANDSCAPE
PART 08: MARKET SEGMENTATION BY END-USER
  • Segmentation by end-user

  • Comparison by end-user

  • Clinics

  • Hospitals

  • Market opportunity by end-user
PART 09: REGIONAL LANDSCAPE
  • Geographical segmentation

  • Regional comparison

  • Americas

  • EMEA

  • APAC

  • Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
  • Market drivers

  • Market challenges
PART 12: MARKET TRENDS
  • Emergence of digital innovations

  • Rise in international accreditation and assistance by hospitals

  • Growth of strategic initiatives for fertility treatments
PART 13: VENDOR LANDSCAPE
  • Overview

  • Landscape disruption
PART 14: VENDOR ANALYSIS
  • Vendors covered

  • Vendor classification

  • Market positioning of vendors

  • Cook Group

  • Hamilton Thorne

  • The Cooper Companies

  • Thermo Fisher Scientific

  • Vitrolife
PART 15: APPENDIX
  • List of abbreviations
List of Exhbits
Exhibit 01: Parent market
Exhibit 02: Global infertility treatment market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global IVF disposables market 2017-2022 ($ mn)
Exhibit 09: Global IVF disposables market – Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Customer landscape
Exhibit 19: End-user – Market share 2017-2022 (%)
Exhibit 20: Comparison by end-user
Exhibit 21: Clinics – Market size and forecast 2017-2022 ($ mn)
Exhibit 22: Clinics – Year-over-year growth 2018-2022 (%)
Exhibit 23: Hospitals – Market size and forecast 2017-2022 ($ mn)
Exhibit 24: Hospitals – Year-over-year growth 2018-2022 (%)
Exhibit 25: Market opportunity by end-user
Exhibit 26: Global – Market share by geography 2017-2022 (%)
Exhibit 27: Regional comparison
Exhibit 28: Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 29: Americas – Year-over-year growth 2018-2022 (%)
Exhibit 30: Top 3 countries in Americas
Exhibit 31: EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 32: EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 33: Top 3 countries in EMEA
Exhibit 34: APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 35: APAC – Year-over-year growth 2018-2022 (%)
Exhibit 36: Top 3 countries in APAC
Exhibit 37: Market opportunity
Exhibit 38: Global hubs for fertility tourism
Exhibit 39: Vendor landscape
Exhibit 40: Landscape disruption
Exhibit 41: Vendors covered
Exhibit 42: Vendor classification
Exhibit 43: Market positioning of vendors
Exhibit 44: Cook Group overview
Exhibit 45: Cook Group– Business segments
Exhibit 46: Cook Group– Organizational developments
Exhibit 47: Cook Group– Geographic focus
Exhibit 48: Cook Group– Segment focus
Exhibit 49: Cook Group– Key offerings
Exhibit 50: Hamilton Thorne overview
Exhibit 51: Hamilton Thorne– Business segments
Exhibit 52: Hamilton Thorne– Organizational developments
Exhibit 53: Hamilton Thorne– Geographic focus
Exhibit 54: Hamilton Thorne– Key offerings
Exhibit 55: The Cooper Companies overview
Exhibit 56: The Cooper Companies– Business segments
Exhibit 57: The Cooper Companies– Organizational developments
Exhibit 58: The Cooper Companies– Geographic focus
Exhibit 59: The Cooper Companies– Segment focus
Exhibit 60: The Cooper Companies– Key offerings
Exhibit 61: Thermo Fisher Scientific overview
Exhibit 62: Thermo Fisher Scientific– Business segments
Exhibit 63: Thermo Fisher Scientific– Organizational developments
Exhibit 64: Thermo Fisher Scientific– Geographic focus
Exhibit 65: Thermo Fisher Scientific– Segment focus
Exhibit 66: Thermo Fisher Scientific– Key offerings
Exhibit 67: Vitrolife overview
Exhibit 68: Vitrolife– Business segments
Exhibit 69: Vitrolife– Organizational developments
Exhibit 70: Vitrolife– Geographic focus
Exhibit 71: Vitrolife– Segment focus
Exhibit 72: Vitrolife– Key offerings

Executive Summary

The publisher recognizes the following companies as the key players in the global IVF disposables market: BIOPSYBELL Srl, Boston IVF, CCD Laboratory, Cook Group Inc., Esco Micro Pte. Ltd., FUJIFILM Corp., Genea Ltd., Hamilton Thorne Ltd., INVO Bioscience Inc., KITAZATO Corp., LabIVF Asia Pte Ltd., Merck KGaA, NidaCon International AB, Progyny Inc., Rocket Medical Plc, Sysmex Corp., Tempest Therapeutics Inc., The Cooper Companies Inc., Thermo Fisher Scientific Inc., and Vitrolife AB.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is technological advancements in IVF procedure.'

According to the report, one of the major drivers for this market is the growing infertility rates.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • BIOPSYBELL Srl
  • Boston IVF
  • CCD Laboratory
  • Cook Group Inc.
  • Esco Micro Pte. Ltd.
  • FUJIFILM Corp.
  • Genea Ltd.
  • Hamilton Thorne Ltd.
  • INVO Bioscience Inc.
  • KITAZATO Corp.
  • LabIVF Asia Pte Ltd.
  • Merck KGaA
  • NidaCon International AB
  • Progyny Inc.
  • Rocket Medical Plc
  • Sysmex Corp.
  • Tempest Therapeutics Inc.
  • The Cooper Companies Inc.
  • Thermo Fisher Scientific Inc.
  • Vitrolife AB